BlackRock Fund Advisors - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$72,517,000
+32.4%
1,420,226
+19.4%
0.01%
+18.2%
Q3 2016$54,758,000
+75.1%
1,189,093
+14.6%
0.01%
+57.1%
Q2 2016$31,273,000
+23.9%
1,037,928
+31.8%
0.01%
+16.7%
Q1 2016$25,249,000
-35.6%
787,546
+17.1%
0.01%
-33.3%
Q4 2015$39,208,000
+25.5%
672,519
-8.9%
0.01%
+12.5%
Q3 2015$31,251,000
-38.4%
738,434
+6.3%
0.01%
-33.3%
Q2 2015$50,696,000
+109.6%
694,471
+44.2%
0.01%
+100.0%
Q1 2015$24,188,000
+43.1%
481,540
+4.2%
0.01%
+50.0%
Q4 2014$16,907,000
+279.0%
461,948
+226.2%
0.00%
+300.0%
Q3 2014$4,461,000141,6070.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders